amosulalol has been researched along with Heart Disease, Ischemic in 1 studies
amosulalol: RN given is for mono-HCl; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with amosulalol, particularly at a dose of 0." | 1.29 | Effects of amosulalol, a combined alpha 1- and beta-adrenoceptor-blocking agent, on ischemic myocardial energy metabolism in dogs. ( Chiba, K; Hayase, N; Ichihara, K, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayase, N | 1 |
| Chiba, K | 1 |
| Ichihara, K | 1 |
1 other study available for amosulalol and Heart Disease, Ischemic
| Article | Year |
|---|---|
Effects of amosulalol, a combined alpha 1- and beta-adrenoceptor-blocking agent, on ischemic myocardial energy metabolism in dogs.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Adrenergic beta-Antagon | 1993 |